IRIS - Res&Arch Institutional Research Information System - Research & Archive

BECATTINI, Cecilia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.030
AS - Asia 5.646
EU - Europa 4.442
SA - Sud America 1.139
Continente sconosciuto - Info sul continente non disponibili 524
AF - Africa 149
OC - Oceania 5
Totale 18.935
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.813
SG - Singapore 2.698
IT - Italia 881
BR - Brasile 869
IE - Irlanda 817
CN - Cina 765
RU - Federazione Russa 757
HK - Hong Kong 695
VN - Vietnam 605
UA - Ucraina 359
DE - Germania 335
FR - Francia 331
SE - Svezia 275
FI - Finlandia 219
GB - Regno Unito 156
BD - Bangladesh 153
IN - India 138
KR - Corea 132
CA - Canada 96
TR - Turchia 89
AR - Argentina 83
MX - Messico 69
IQ - Iraq 65
AT - Austria 55
PL - Polonia 48
PK - Pakistan 45
EC - Ecuador 40
ES - Italia 39
NL - Olanda 39
ZA - Sudafrica 37
CO - Colombia 36
JP - Giappone 34
UZ - Uzbekistan 34
VE - Venezuela 32
CH - Svizzera 29
CL - Cile 28
SA - Arabia Saudita 24
ID - Indonesia 23
JO - Giordania 21
TN - Tunisia 21
EG - Egitto 19
LB - Libano 17
LT - Lituania 17
MA - Marocco 17
PH - Filippine 17
KE - Kenya 16
PE - Perù 14
PY - Paraguay 14
AE - Emirati Arabi Uniti 13
BE - Belgio 13
CR - Costa Rica 11
JM - Giamaica 11
MY - Malesia 11
BO - Bolivia 10
CZ - Repubblica Ceca 10
UY - Uruguay 10
GR - Grecia 9
MK - Macedonia 9
PS - Palestinian Territory 9
BG - Bulgaria 8
DZ - Algeria 8
OM - Oman 8
RO - Romania 8
NP - Nepal 7
AZ - Azerbaigian 6
ET - Etiopia 6
IL - Israele 6
KG - Kirghizistan 6
TT - Trinidad e Tobago 5
AL - Albania 4
AO - Angola 4
CI - Costa d'Avorio 4
DK - Danimarca 4
EU - Europa 4
GT - Guatemala 4
KH - Cambogia 4
KW - Kuwait 4
PT - Portogallo 4
BB - Barbados 3
HN - Honduras 3
KZ - Kazakistan 3
NI - Nicaragua 3
RS - Serbia 3
SN - Senegal 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
BW - Botswana 2
BY - Bielorussia 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
GP - Guadalupe 2
GY - Guiana 2
HR - Croazia 2
HU - Ungheria 2
IR - Iran 2
LY - Libia 2
MD - Moldavia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
Totale 18.386
Salva come PNG Salva come JPEG
Città #
Singapore 1.939
Chandler 887
Dublin 812
Hong Kong 693
San Jose 668
Ashburn 481
San Mateo 381
Dong Ket 295
Moscow 295
Santa Clara 281
Boardman 254
Altamura 228
Perugia 227
Lauterbourg 214
Medford 204
Princeton 200
Lawrence 194
Jacksonville 181
Beijing 174
Los Angeles 144
Ann Arbor 133
New York 133
Seoul 132
Wilmington 130
Ho Chi Minh City 128
Munich 113
Des Moines 111
Andover 103
The Dalles 82
São Paulo 80
Piscataway 67
Hanoi 66
Helsinki 63
Redmond 55
San Paolo di Civitate 53
Dallas 51
Nuremberg 48
Orem 44
Frankfurt am Main 42
Saint Petersburg 42
Izmir 40
Chicago 39
Montreal 38
Norwalk 38
Turku 38
Phoenix 36
Brooklyn 32
Shanghai 31
Warsaw 31
Rome 30
Baghdad 28
Rio de Janeiro 27
Stockholm 27
Tokyo 26
Columbus 25
Denver 25
Hefei 25
Falls Church 24
Chennai 23
Atlanta 22
Houston 22
London 21
Milan 21
Boston 20
Buffalo 20
Johannesburg 20
Lahore 20
Amelia 19
Tashkent 19
Toronto 19
Manchester 18
Amman 17
Redwood City 17
San Francisco 17
Amsterdam 16
Brasília 16
Seattle 16
Mexico City 15
Nairobi 15
Vienna 15
Belo Horizonte 14
Bologna 14
Da Nang 14
Mumbai 14
Quito 14
Dhaka 13
Naples 13
New Delhi 13
Ribeirão Preto 13
Woodbridge 13
Brussels 12
Guarulhos 12
Poplar 12
Ankara 11
Bogotá 11
Charlotte 11
Curitiba 11
Haiphong 11
Jeddah 11
Lappeenranta 11
Totale 11.644
Salva come PNG Salva come JPEG
Nome #
The sentinel node biopsy in patients with thick melanoma:outcome analysis from a single-institution database 161
Bedside sonography assessment of extravascular lung water increase after major pulmonary resection in non-small cell lung cancer patients 150
Prognostic role of sentinel node biopsy in patients with thick melanoma: a meta-analysis. 149
Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients 145
Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model 142
Aspirin for preventing the recurrence of venous thromboembolism. 136
Anticoagulation after Stroke in Patients with Atrial Fibrillation: To Bridge or Not with Low-Molecular-Weight Heparin? 135
Prestroke CHA2DS2-VASc Score and Severity of Acute Stroke in Patients with Atrial Fibrillation: Findings from RAF Study 127
Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study 124
Prognostic value of trans-thoracic echocardiography in patients with acute stroke and atrial fibrillation: findings from the RAF study 123
Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: Time to initiation of oral anticoagulant therapy and outcomes 119
Search for SARS-CoV-2 RNA in platelets from COVID-19 patients 118
Sex-related differences in risk factors, type of treatment received and outcomes in patients with atrial fibrillation and acute stroke: Results from the RAF-study (Early Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation) 116
Safety and efficacy of concomitant treatment with non-vitamin K antagonist oral anticoagulants and antiseizure medications: A propensity score matching cohort study 114
96 hours ECGmonitoring for patients with ischemic cryptogenic stroke or transient ischaemicattack. 113
[ANMCO Position paper: Recommendations for the follow-up of patients with pulmonary thromboembolism] 113
Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients with Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score Study 112
A prospective study on cardiovascular events after acute pulmonary embolism 111
Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study 109
Definition of major bleeding: Prognostic classification 108
A new strategy for anticoagulation: The factor XI inhibitors 107
Acute pulmonary embolism: external validation of an integrated risk stratification model. 107
Acute pulmonary embolism: external validation of the 2014 risk stratification model of the European Society of Cardiology 107
Patients aged 90  years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study 107
Anticoagulation for atrial fibrillation in patients with active cancer: Reply to the ‘Letter to the Editor’ from Dr. Sorigue et al 107
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism 106
A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. 106
Acute cardiovascular events in patients with community acquired pneumonia: results from the observational prospective FADOI-ICECAP study 106
Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis 105
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC) 105
[ANMCO position paper: Use of new oral anticoagulants for the treatment and prevention of pulmonary thromboembolism] 104
Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcme-based meta-analysis 103
Association of Neutrophil Activation, More Than Platelet Activation, with Thrombotic Complications in Coronavirus Disease 2019 103
Association of persistent right ventricular dysfunction at hospital discharge after acute pulmonary embolism with recurrent thromboembolic events 102
Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with Non-Vitamin-K oral anticoagulants (RAF-NOACs) Study 102
Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation 102
Bosentan for chronic thromboembolic pulmonary hypertension: findings from a systematic review and meta-analysis. 102
Risk factors for adverse short-term outcome in patients with pulmonary embolism 101
Initial treatment of venous thromboembolism 101
D-dimer for riskstratification in patients with acute pulmonary embolism. 101
Risk of recurrent venous thromboembolism after acute pulmonary embolism: Role of residual pulmonary obstruction and persistent right ventricular dysfunction. A meta-analysis 101
Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation 101
Acute pulmonary embolism. 100
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 99
[Determinants of prognosis in acute pulmonary embolism: the role of serum troponins]. 99
Acute pulmonary embolism: risk stratification in the emergency department. 99
Early recurrence in paroxysmal versus sustained atrial fibrillation in patients with acute ischaemic stroke 99
Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study 98
Safety of Anticoagulation in Patients Treated with Urgent Reperfusion for Ischemic Stroke Related to Atrial Fibrillation 97
Incidence of venous thromboembolism in patients undergoing laparoscopic surgery for colorectal cancer 96
Mortality in patients with intracerebral hemorrhage associated with antiplatelet agents, oral anticoagulants or no antithrombotic therapy 96
Venous thromboembolism and atherosclerosis: common denominators or different diseases? 95
ECOGRAFICA TRANS-TORACICA NELLA VALUTAZIONE DEI FLUIDI POLMONARI EXTRAVASCOLARI DOPO CHIRURGIA TORACICA MAGGIORE 95
Apixaban for the treatment of venous thromboembolism associated with cancer 95
Acute Pulmonary Embolism after Discharge: Duration of Therapy and Follow-up Testing 94
Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy 93
Aspirin for the prevention of recurrent venous thromboembolism the INSPIRE collaboration 93
PO-40 - Real-life use of non-vitamin k antagonist oral anticoagulants in patients with cancer associated venous thromboembolism: data from a prospective cohort 93
Rivaroxaban for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer. Design of the PRO-LAPS II STUDY 93
Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism 93
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS) 93
Reperfusion therapies in patients with acute ischaemic stroke and atrial fibrillation: data on safety and effectiveness from a multi-centre cohort study 93
New anticoagulants 92
Incidence and risk factors for venous thromboembolism after laparoscopic surgery for colorectal cancer 92
Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation 92
Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis 92
Effects of concomitant administration of anticancer agents and apixaban or dalteparin on recurrence and bleeding in patients with cancer-associated venous thromboembolism 92
Challenging anticoagulation cases: A case of pulmonary embolism shortly after spontaneous brain bleeding 91
Concomitant Use of Direct Oral Anticoagulants and Antiepileptic Drugs: A Prospective Cohort Study in Patients with Atrial Fibrillation 91
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: Systematic review and meta-analysis 90
A Randomized Study on 1-Week Versus 4-Week Prophylaxis for Venous Thromboembolism After Laparoscopic Surgery for Colorectal Cancer Reply 89
Use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life: comparison with phase III trials 89
Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism 89
Acute treatment of venous thromboembolism 89
Thrombolysis in submassive pulmonary embolism 89
Recurrent venous thromboembolism in men and women 88
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study 88
Oxygen saturation or respiratory rate to improve risk stratification in hemodynamically stable patients with acute pulmonary embolism 88
ANMCO statement: Arterial and venous thromboembolism: What implications for clinical practice? 88
Direct thrombin inhibitors for the prevention of venous thromboembolism after major orthopaedic surgery 87
Prognostic value of respiratory index in haemodynamically stable patients with acute pulmonary embolism: The Respiratory Index model study 87
Association of Neutrophil Activation, More Than Platelet Activation, with Thrombotic Complications in Coronavirus Disease 2019 87
PREvention of VENous Thromboembolism in Hemorrhagic Stroke Patients-PREVENTIHS Study: A Randomized Controlled Trial and a Systematic Review and Meta-Analysis 87
Combined oral anticoagulants and antiplatelets: benefits and risks. 86
Lo studio EINSTEIN CHOICE 86
Anticoagulation in acute ischemic stroke patients with mechanical heart valves: To bridge or not with heparin. The ESTREM study 85
Multidetector CT scan for acute pulmonary embolism: Embolic burden and clinical outcome 85
Padua prediction score or clinical judgment for decision making on antithrombotic prophylaxis: a quasi-randomized controlled trial 85
Rivaroxaban versus placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer 85
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation. 84
Global thromboelastometry in patients receiving direct oral anticoagulants: the RO-DOA study 84
Efficacy and safety of anticoagulant agents in patients with venous thromboembolism and cancer: A network meta-analysis 83
Cardiovascular risk factors and venous thromboembolism: a meta-analysis. 83
Platelets from COVID-19 Patients Show an Altered Nitric Oxide/Reactive Oxygen Species Production Balance 82
Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism 82
Vitamin K and non-vitamin K antagonists oral anticoagulants for non-valvular atrial fibrillation in real-life 82
Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study 82
Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial 82
Updated meta-analysis on prevention of venous thromboembolism in ambulatory cancer patients 82
A platelet lipidomics signature in patients with COVID-19 81
Totale 10.020
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.765
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.765
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.539 0 259 20 50 81 19 14 457 52 111 220 256
2022/20233.014 221 658 38 206 233 347 0 110 1.063 13 91 34
2023/20241.065 80 110 71 15 12 5 261 32 67 59 212 141
2024/20253.286 24 270 89 152 383 253 139 258 685 214 523 296
2025/20267.312 585 519 428 952 980 554 1.299 383 666 573 260 113
2026/2027485 184 301 0 0 0 0 0 0 0 0 0 0
Totale 18.935